PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
2 hedge funds and large institutions have $44K invested in PAVmed Inc. Warrant in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
51% less capital invested
Capital invested by funds: $90K → $44K (-$46K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$14.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.51K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCS
1
Levin Capital Strategies
New York
| $42K | +$14.3K | +12,528 | +23% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$4.51K | +3,949 | New |
|
PAVMW Hedge Fund Activity: Q4 2017 in Review
2 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q4 2017, worth a combined $44K — down 51% from $90K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PAVMW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $14.3K.
- 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q4 2017, up from 1 in Q3 2017.
- Funds reported $44K of PAVmed Inc. Warrant stock for Q4 2017, down 51% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Warrant positions in Q4 2017 and 0 closed out, a net change of +1 holder.
- The largest PAVmed Inc. Warrant buyer in Q4 2017 was Levin Capital Strategies, an estimated $14.3K added.
Based on aggregated 13F filings for Q4 2017.